NCT06440005 2026-02-11A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.Phase 1 Recruiting80 enrolled
NCT06277154 2025-07-24MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaHRYZ Biotech Co.Phase 2 Recruiting148 enrolled